Omeros | OMER - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Adma Biologics USD 511.17M 44.66M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Cytokinetics USD 839.46M 77.51M 2026-03
Gilead Sciences USD 18.64B 1.25B 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Immunic USD 188.76M 165.89M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Knight Therapeutics CAD 394.84M 5.86M 2025-12
MacroGenics USD 182.52M 37.42M 2026-03
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 514.96M 33.01M 2026-03
Pfizer USD 42.82B 76M 2026-03
Rockwell Medical USD 31.61M 1.42M 2025-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
United Therapeutics USD 2.87B 830.5M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03
Xoma USD 110.71M 5.78M 2025-09